SpyGlass Pharma, Inc. (SGP) income statement
SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$30.43−0.35 (-1.14%)
Close on Nov 20, 2026Market cap $1.02BP/E –Yield –
SpyGlass Pharma, Inc. financial ratios
See a number that looks wrong?